Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/46598
Campo DC Valoridioma
dc.contributor.authorRodríguez De Castro, Felipeen_US
dc.contributor.authorNaranjo, Olga Rajasen_US
dc.contributor.authorMarco, Javier Aspaen_US
dc.date.accessioned2018-11-23T06:11:58Z-
dc.date.available2018-11-23T06:11:58Z-
dc.date.issued2007en_US
dc.identifier.issn0300-2896en_US
dc.identifier.urihttp://hdl.handle.net/10553/46598-
dc.description.abstractThe first line of defense against invasion and dissemination of pathogens involves their recognition and elimination as well as an inflammatory and antiinflammatory response. These processes can be affected by polymorphisms of the genes involved. The magnitude of the inflammatory response against infection should be proportional and should be adequately compartmentalized. Plasma levels of inflammatory mediators are related to the severity of pneumonia and some of these markers seem promising for use in diagnosis, prognosis and therapeutic management. Because pneumonia can progress due to an unbalanced inflammatory response, even when antibiotic therapy is provided, a logical strategy would be to attempt to attenuate the magnitude of this response through other therapeutic interventions. The most effective compounds are those able to stimulate early defenses and the elimination of new organisms without influencing the late phases of inflammatory injury.en_US
dc.languageengen_US
dc.relation.ispartofArchivos de Bronconeumologiaen_US
dc.sourceArchivos de Bronconeumologia [ISSN 0300-2896],v. 43, p. 31-39en_US
dc.subject32 Ciencias médicasen_US
dc.subject320508 Enfermedades pulmonaresen_US
dc.subject.otherLung infectionsen_US
dc.subject.otherInflammatory responseen_US
dc.titleLung infectionsen_US
dc.typeinfo:eu-repo/semantics/reviewen_US
dc.typeArticleen_US
dc.identifier.scopus34547823462-
dc.contributor.authorscopusid55942667000-
dc.contributor.authorscopusid18437564700-
dc.contributor.authorscopusid18437869600-
dc.description.lastpage39en_US
dc.description.firstpage31en_US
dc.relation.volume43en_US
dc.type2Reseñaen_US
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.date.coverdateJunio 2007en_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr1,563
dc.description.jcrqQ4
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Patología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-6812-2739-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez De Castro, Felipe Carlos B.-
Colección:Reseña
Vista resumida

Visitas

31
actualizado el 06-ene-2024

Google ScholarTM

Verifica


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.